Skip to main
UTHR
UTHR logo

United Therapeutics (UTHR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy United Therapeutics (UTHR) Stock

About United Therapeutics (UTHR)

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Market cap$12.78B
Friday's volume564.44K
Revenue (TTM)$2.99B
Avg. daily volume530.12K
EBITDA (TTM)$1.48B
Open$283.55
Price / earnings ratio11.31x
Friday's range$282 - $287.12
Debt / equity2.94x
52 week range$266.98 - $417.82
5 year debt / equity13.09x
Beta (LTM)0.57x
Interest coverage32.1x
Dividend & yield$0.00 (0.00%)
Current ratio5.46x
Ex-dividend date
Next earningsJul 30, 2025
Dividend payable date

United Therapeutics Stock Rating

What analysts recommend for UTHR stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 33%
Buy 29%
Hold 33%
Sell 4%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 14, 2025, the market cap for UTHR stock is $12.79B

The current P/E ratio for UTHR stock is 11.31

The 52-week high for UTHR stock is $417.82. The current UTHR stock price $undefined is 100.00% below its 52-week high

The 52-week low for UTHR stock is $266.98. The current UTHR stock price $undefined has increased 100.00% from its 52-week low

No, the UTHR stock does not pay dividends to its shareholders

The target price for UTHR stock is $282.25 based on the average of what a group of analyst think UTHR stock could be worth at a future date. This is not a prediction by Public.com

How to buy UTHR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in UTHR stock

    Navigate to the Explore page. Then, type UTHR into the search bar. When you see UTHR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased UTHR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

United Therapeutics Stock Earnings

The value each UTHR share was expected to gain vs. the value that each UTHR share actually gained.

United Therapeutics (UTHR) reported Q1 2025 earnings per share (EPS) of $6.63, beating estimates of $6.53 by 1.53%. In the same quarter last year, United Therapeutics's earnings per share (EPS) was $6.17. United Therapeutics is expected to release next earnings on 07/30/2025, with an earnings per share (EPS) estimate of $0.

Buy United Therapeutics (UTHR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.